share_log

Ginkgo Bioworks | 144: Notice of proposed sale of securities pursuant to Rule 144

Ginkgo Bioworks | 144: Notice of proposed sale of securities pursuant to Rule 144

Ginkgo Bioworks | 144:拟议出售证券
美股sec公告 ·  04/29 10:43
Moomoo AI 已提取核心信息
Ginkgo Bioworks Holdings, Inc. officer Che Austin is set to sell 3,968 Class A shares on 04/29/2024, as per the latest filing. These shares, valued at an aggregate market value of $3,412.88, were originally acquired on 10/07/2022 as part of a restricted stock vesting and were compensation for services rendered. This planned sale follows a significant transaction history over the past few months, where a total of 249,984 shares were sold by the officer, generating gross proceeds of $293,057.86. The notice of the upcoming sale was filed on the same date as the planned sale, with the instruction for this transaction having been given on 03/14/2023.
Ginkgo Bioworks Holdings, Inc. officer Che Austin is set to sell 3,968 Class A shares on 04/29/2024, as per the latest filing. These shares, valued at an aggregate market value of $3,412.88, were originally acquired on 10/07/2022 as part of a restricted stock vesting and were compensation for services rendered. This planned sale follows a significant transaction history over the past few months, where a total of 249,984 shares were sold by the officer, generating gross proceeds of $293,057.86. The notice of the upcoming sale was filed on the same date as the planned sale, with the instruction for this transaction having been given on 03/14/2023.
根据最新文件,Ginkgo Bioworks Holdings, Inc.高管切·奥斯汀定于2024年4月29日出售3,968股A类股票。这些股票的总市值为3,412.88美元,最初于2022年7月10日作为限制性股票归属的一部分收购,是对所提供服务的补偿。此次计划出售遵循了过去几个月的重大交易记录,该官员共出售了249,984股股票,总收益为293,057.86美元。即将进行的出售通知与计划出售的日期相同,该交易的指示已于2023年3月14日发出。
根据最新文件,Ginkgo Bioworks Holdings, Inc.高管切·奥斯汀定于2024年4月29日出售3,968股A类股票。这些股票的总市值为3,412.88美元,最初于2022年7月10日作为限制性股票归属的一部分收购,是对所提供服务的补偿。此次计划出售遵循了过去几个月的重大交易记录,该官员共出售了249,984股股票,总收益为293,057.86美元。即将进行的出售通知与计划出售的日期相同,该交易的指示已于2023年3月14日发出。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息